Nuclear expression of survivin has been correlated with relapse-free prognosis for some cancer patients (Knauer et al., 2007) and longer survival in others (Okada et al., 2001; Tonini et al., 2005), although several papers argue the opposite (see Wheatley, 2011). This evidence concerns the gene BIRC5 and cancer.